Aventis Pharma, the pharmaceutical unit of Aventis, has said it would pay Millennium Pharmaceuticals $450 million for a stake in the company as well as for the rights to its drug discovery technologies.
Aventis Pharma, the pharmaceutical unit of Aventis, has said it would pay Millennium Pharmaceuticals $450 million for a stake in the company as well as for the rights to its drug discovery technologies.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.